Review article: Luminex technology for HLA antibody detection in organ transplantation

Nephrology

Volumn 14, Issue 2, 2009, Pages 247-254

  Tait, Brian D ^a,b   Hudson, Fiona ^b   Cantwell, Linda ^b   Brewin, Gemma ^b   Holdsworth, Rhonda ^b   Bennett, Greg ^b   Jose, Matthew ^c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Anti HLA antibodies; Rejection; Renal; Solid phase assays

Indexed keywords

COMPLEMENT FIXING ANTIBODY; HLA ANTIBODY; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALGORITHM; ALLELE; ANTIBODY DETECTION; ARTICLE; BIOASSAY; COST BENEFIT ANALYSIS; DESENSITIZATION; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; LUMINEX SYSTEM; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ALGORITHMS; ALLELES; COST-BENEFIT ANALYSIS; CYTOTOXICITY TESTS, IMMUNOLOGIC; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MICROSPHERES; ORGAN TRANSPLANTATION; SENSITIVITY AND SPECIFICITY;

EID: 63849151197     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01074.x     Document Type: Article

References (53)

1. Patel R, Terasaki P. Significance of the positive crossmatch in kidney transplantation. N. Eng. J. Med. 1969 280 : 735 9.
2. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotxins. Nature 1964 204 : 998 1000.
3. Fuller TC, Cosimi AB, Russell PS. Use of an anti-globulin - ATG reagent for detection of low levels of alloantibody - improvement of allograft survival in pre sensitised recipients. Trans. Proc. 1978 10 : 463 6.
4. Ting A, Hasegawa T, Ferrone S, Reisfeld RA. Pre-sensitization detected by sensitive crossmatch tests. Transpl. Proc 1973 5 : 813 17.
5. Bryan CF, Baier KA, Nelson PW et al. Long term graft survival is improved in cadaveric renal transplantation renal transplantation by Flow cytometeric crossmatching. Transplantation 1998 66 : 1827 32.
6. Mahoney RJ, Ault KA, Given SR et al. The flow cytometric crossmatch and early renal transplant loss. Transplantation 1990 49 : 527 35.
7. Karpinksi M, Rush D, Jeffery J et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J. Am. Soc. Nephrol. 2001 12 : 2807 14.
8. Kao KJ, Scornik JC, Small JC. Enzyme linked immunoassay for anti-HLA antibodies-an alternative to panel studies by lymphocytotoxicity. Transplantation 1993 55 : 192 6.
9. Monien S, Salama A, Schonemann C. ELISA methods detect HLA antibodies with variable sensitivity. Int. J. Immunogenet. 2006 33 : 163 6.
10. Worthington JE, Robson AJ, Sheldon S, Langton A, Martin S. A comparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies. Hum. Immunol. 2001 62 : 1178 84.
11. Rebibou JM, Chabod J, Bittencourt MC et al. Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation. Transpl. Immunol. 2000 8 : 125 8.
12. Colombo MB, Haworth SE, Poli F et al. Luminex technology for anti-HLA antibody screening: Evaluation of performance and of impact on laboratory routine. Cytometry B Clin. Cytom. 2007 72 : 465 71.
13. Saidman SL. Histocompatibility testing for highly sensitised transplant candidates. Trans. Proc. 2007 39 : 673 5.
14. Leffell MS, Montgomery RA, Zachary AA. The changing role of antibody testing in transplantation. Clin. Transpl. 2005 259 71.
15. Zeevi A, Girnita A, Duquesnoy R. HLA antibody analysis: Sensitivity, specificity and clinical significance in solid organ transplantation. Immunol. Res. 2006 36 : 255 64.
16. Pretl K, Chesterton KA, Scholander JT, Leffell MS, Zachary AA. Accurate rapid characterisation of HLA specific antibodies using Luminex technology. Hum. Immunol. 2003 64 (Suppl 1 pS108.
17. Phelan D, Pang S, Phelan C, Grant G, Land G. When is sensitive too sensitive? Hum. Immunol. 2007 68 (Suppl 1 27.
18. Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC. Detection of donor specific antibodies using HLA coated microspheres: Another tool for kidney transplant risk stratification. Nephrol. Dial. Transplant. 2006 21 : 2625 9.
19. Smith JD, Hamour IM, Banner NR, Rose ML. C4d fixing Luminex antibodies - A new tool for prediction of graft failure after heart transplantation. Am. J. Transplant. 2007 7 : 2809 15.
20. Cherikh W, Baker T, Nelson K, Land G, Leffell M, Nikaein A. Broader geographic sharing through accurate prediction of crossmatch results. Abstract 868. The First joint International Transplant Meeting, Boston Massachusetts, July 2006.
21. Vaidya S, Partlow D, Susskind B, Noor M, Barnes T, Gugliuzza K. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation 2006 82 : 1524 8.
22. Vaidya S, Partlow DA, Suskind B, Gugliuzzi K. Prediction of crossmatch outcome of highly sensitised patients based on identification of class 1 and 2 antibodies by single and/or multiple antigen bead Luminex assay. Abstract 870. The First Joint International Transplant Meeting, Boston, Massachusetts, July 2006.
23. Mizutani K, Terasaki P, Hamdani E et al. The importance of anti HLA-specific antibody strength in monitoring kidney transplant patients. Am. J. Transplant. 2007 7 : 1027 31.
24. McCalmon RT, Tardif GN, Sheehan MA, Fitting K, Kortz W, Kam I. IgM antibodies in renal transplantation. Clin. Transplant. 1997 11 : 558 64.
25. Marcen R, Ting A, Taylor CJ, Miach PJ, Chapman JR, Morris PJ. Immunoglobulin class and specificity of lymphocytotoxic antibodies after kidney transplantation. Nephrol. Dial. Transplant. 1988 3 : 809 13.
26. Heinemann FM, Roth I, Rebmann V et al. Immunoglobulin isotype-specific characterisation of anti-human leukocyte antigen antibodies eluted from explanted renal allografts. Hum. Immunol. 2007 68 : 500 6.
27. Wahrmann M, Exner M, Regele H et al. Flow cytometry based detection of HLA alloantibody mediated classical complement activation. J. Immunol. Methods 2003 275 : 149 60.
28. Wahrmann M, Exner M, Schillinger M et al. Pivotal role of complement fixing HLA antibodies in pre-sensitised kidney allograft recipients. Am. J. Transplant. 2006 6 (5 Pt 1 1033 41.
29. El-Awar N, Lee J, Terasaki PI. HLA antibody identification with single antigen beads compared to conventional methods. Hum. Immunol. 2005 66 : 989 97.
30. McKenna RM, Takemoto SK, Teresaki PI. Anti HLA antibodies after solid organ transplantation. Transplantation 2000 69 : 319 26.
31. Camposa EF, Tedesco-Silver H, Machado PG, Franco M, Medina-Pestano JO, Gerbase-DeLima MP. Post transplant anti-HLA class 2 antibodies as risk factor for late kidney allograft failure. Am. J. Transplant. 2006 6 : 2316 20.
32. Blair S, Tait B, Hudson F, Kannellis J. Acute humoral rejection associated with HLA-DOB1 antibody in an HLA identical (A, B, DR, DQ) recipients. Abstract - Transplantation Society of Australia and New Zealand Annual Scientific Meeting Canberra, Australia, April 2007.
33. Piazza A, Poggi E, Ozzella G et al. Anti-DP antibodies and graft failure Abstract 520 The First Joint International Transplant Meeting. Boston, Massachusetts, July, 2006.
34. Qiu J, Cai J, Terasaki PI, El-Awar N, Lee JH Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads. Transplantation 2005 80 : 1511 13.
35. Arnold ML, Pei R, Spriewald B, Wassmuth R. Anti-HLA class 2 antibodies in kidney re-transplant patients. Tissue Antigens 2005 65 : 370 78.
36. Mizutani K, Terasaki PI, Rosen A et al. Serial ten year follow up of HLA and MICA antibody production prior to kidney graft failure. Am J. Transplant. 2005 5 : 2265 72.
37. Mizutani K, Terasaki P, Bignon JD et al. Association of kidney transplant failure and antibodies against MICA. Hum. Immunol. 2006 67 : 683 91.
38. Panigrahi A, Gupta N, Siddiqui JA et al. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Hum. Immunol. 2007 68 : 362 67.
39. Pancoska C, Breed R, Harris P, Sonuga B, Venzon l. Emergent PRA technologies may detect unexpected antibodies in the sera of solid organ transplant recipients. One Lambda Advanced LABMAS Workshop, Los Angeles, August 14-17th, 2007.
40. Rosen-Bronsen S. A*0301 specific HLA detected in the serum of an A*0302 positive renal transplant recipient. One Lambda Advanced LABMAS Workshop, Los Angeles, August 14th-17th, 2007.
41. Tait BD, Dandie WJ, Griffiths AP et al. Covert pre-sensitisation to HLA antigens in parous heart and lung transplant recipients may pre-dispose to early allograft rejection. Transplant. Proc. 1995 27 : 2143 4.
42. Cabacungan C. Re-grafts. Clin. Transplant. 1992 347 56.
43. Heise ER, Thacker LR, MacQueen JM, Peter TG. Repeated HLA mismatches and second renal graft survival in centres of the South Eastern Organ Procurement Foundation. Clin. Transplant. 1996 10 (6 Pt 2 579 85.
44. Farney AC, Matas AJ, Noreen HJ et al. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival. Cell Transplant. 1996 10 : 147 56.
45. Cecka JM, Terasaki PI. Repeating HLA antigen mismatches in renal transplants - A second class mistake? Transplantation 1994 57 : 515 19.
46. Bray RA, Nolen JD, Larsen C et al. Transplanting the highly sensitised patient: The Emory algorithm. Am. J. Transplant. 2006 6 : 2307 15.
47. Iwaki Y, Cook DJ, Terasaki PI et al. Flow cytometry crossmatching in human cadaveric kidney transplantation. Trans. Proc. 1987 19 (1 pt 1 764 6.
48. Scornik JC. Detection of alloantibodies by flow cytometry: Relevance to clinical transplantation. Cytometry 1995 22 : 259 63.
49. O'Rourke RW, Osario RW, Friese CE et al. Flow cytometry crossmatching as a predictor of acute rejection in sensitised recipients of cadaveric renal transplants. Clin. Transplant. 2000 14 : 167 73.
50. TM donor specific antibody detection, 2008 Cited 5 December 2008.] Available from URL: http://www.tepnel.com/td-dsa-donor-specific-antibody.asp
51. Cass A, Chadban S, Craig J et al. The economic impact of end-stage kidney disease in Australia. Report by the George Institute for International Health to Kidney Health Australia, Melbourne, 2006. [Cited 5 December 2008.] Available from URL: http://www.kidney.org.au/
52. Jordan SC, Cunningham-Randles C, McEwan R. Utility of Intravenous immune globulin in kidney transplantation: Efficacy, safety and cost implications. Am. J. Transplant. 2003 3 : 653 64.
53. McLaughlin K, Manns B, Nickerson P. The routine use of high-resolution immunological screening of recipients of primary deceased donor kidney allografts is cost-effective. Transplantation 2006 81 : 1278 84.